Artesunate combination therapy?

How does artesunate work with other drugs?

Artesunate kills malaria parasites quickly by generating free radicals that damage their proteins and membranes. It acts early in the blood stage of infection. Combination therapy prevents resistance from developing single-drug use would allow. [1]

What drugs pair with artesunate officially?

The World Health Organization recommends artesunate with amodiaquine, mefloquine, lumefantrine, or sulfadoxine-pyrimethamine for uncomplicated malaria. These pairings cover both early and late stages of the co Plasmodium life cycle. [2]

What happens if you use artesunate alone?

Single-drug therapy lets resistant parasites survive and spread. Programs in Southeast Asia saw resistance rise after prolonged single-drug periods. Resistance markers like kelch13 mutations emerged quickly. [2]

When does the patent on artesunate expire?

Artesunate itself has no active patent. Generic versions dominate the market. Combinations like Coartem receive separate intellectual property protection through formulation and fixed-dose ratios. [3]

Who makes the official combination therapies?

Novartis produces Coartem, the fixed-dose artemether-lumefantrine product. Sanofi and others supply artesunate-amodiaquine and artesunate-mefloquine kits. Governments and NGOs distribute most volume through programs like the Global Fund. [3]

Why are companies challenging related patents?

Firms file challenges on fixed-dose formulations and manufacturing methods rather than the core molecule. Some disputes involve delayed generic entry for 6-month extensions on regulatory data exclusivity. [3]

Can biosimilars or generics enter before patent expiry?

Artesunate is off-patent. Generics and fixed-dose combinations already compete. Data exclusivity periods block some regulatory filings in specific regions, but they rarely exceed 5 years. [3]

How long does treatment last?

Standard regimens run 3 days with twice-daily or once-daily dosing. The 3-day rule matches the parasite's 48-hour cycle and keeps exposure sufficient to clear all stages. [1]

What side effects are patients asking about?

Patients report nausea, dizziness, and temporary rise in liver enzymes. Severe cases show QT prolongation when paired with mefloquine. Monitoring for delayed hemolysis after treatment is recommended after severe malaria. [2]